Maximize the insights gained from PDX Models
Our optimized PDX engraftment procedures and modern technologies, such as multi-omics, digital spatial analysis and biodistribution, boost the utilization of PDX models and provide comprehensive insights into their molecular landscape. To utilize the unique genomic features of PDX models obtained from patients of diversified cancer subtypes, stages and treatment backgrounds, we offer a broad range of ex vivo analysis capabilities . Additionally, we offer a variety of therapeutic approaches including adoptive cell therapies and combination therapies with radiation and radiopharmaceuticals to support your oncology research program. With our full suite of in vivo and ex vivo capabilities, you can maximize the insights gained from the unique features of PDX models.
Oncology experience you can count on
With more than 10 000 studies completed, we have amassed extensive experience and deep insights to inform end-to-end discovery oncology research. Notre équipe vous aide à explorer les effets des médicaments et des médicaments biologiques à l'aide de modèles tumoraux humains et syngéniques. Elle vous fournit des données qui vous aident à prendre des décisions et à faire progresser votre médicament candidat vers la prochaine avancée en matière de recherche sur le cancer. And if you are ready to move a lead candidate to IND/CTA and beyond, we have the unique ability to support you with testing throughout the entire development journey, anchored by a biomarker-driven strategy. With our experience, we help you gain efficiencies as we connect insights effectively from one stage to the next, empowering you to make more informed decisions every step of the way.